Clinical Trial Update: Capecitabine, Docetaxel and Gemcitabine in Patients With Advanced Pancreas Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a triple-drug combination of capecitabine, docetaxel, and gemcitabine in advanced pancreatic cancer; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• DOCETAXEL (DOCETAXEL)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Tony Bekaii-Saab | Conditions: Pancreatic Cancer | Phase 1 | Status: COMPLETED | Results posted: 2015-10-19